KDB Life Main Bid: Three-Way Race Among Hanwha, Heungkuk, and Korea Investment as Samsung and Kyobo Sit Out

Korea Development Bank's Capital Injection Remains Variable
Three Acquisition Candidates Enter Full Competition

In the main bidding round for the sale of KDB Life Insurance, Hanwha Life Insurance, Heungkuk Life Insurance, and Korea Investment Holdings submitted final acquisition proposals, resulting in a three-way competition.

KDB Life Insurance. Photo by Yongjun Cho

According to financial industry sources on August 7, Hanwha Life Insurance, Heungkuk Life Insurance, and Korea Investment Holdings submitted their final acquisition proposals by 3 p.m. that day for the main bidding round of the KDB Life Insurance sale.

Samsung Life Insurance and Kyobo Life Insurance, which had participated in the preliminary bidding, did not join the main bidding. Samsung Life Insurance is reported to have determined, after due diligence, that there would not be significant acquisition synergies.

This marks the seventh attempt by Korea Development Bank to sell KDB Life Insurance, and the participation of three candidates is seen to increase the likelihood that the sale process, which has continued for 12 years, will finally be completed.

However, the ultimate outcome will likely depend on the size of the pre-transaction capital increase by Korea Development Bank. The acquisition candidates have each proposed the necessary amounts for capital increase, and the core criterion for selecting the preferred negotiating partner is expected to be the extent to which Korea Development Bank's additional financial burden can be minimized.

Korea Development Bank and the sale manager, Samil PricewaterhouseCoopers, plan to select a preferred bidder later this month and aim to sign a stock purchase agreement (SPA) within the year.

This content was produced with the assistance of AI translation services.